{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:39:39Z","timestamp":1776512379173,"version":"3.51.2"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jmdjournal.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jmoldx.2023.03.008","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T05:51:43Z","timestamp":1681537903000},"page":"477-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Validation of the Labcorp Plasma Focus Test to Facilitate Precision Oncology Through Cell-Free DNA Genomic Profiling of Solid Tumors"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0208-4784","authenticated-orcid":false,"given":"Ellen L.","family":"Verner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5998-1999","authenticated-orcid":false,"given":"Jennifer B.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Severson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3858-1923","authenticated-orcid":false,"given":"Kenneth C.","family":"Valkenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy E.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2916-5269","authenticated-orcid":false,"given":"Mark","family":"Sausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Maddox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Paul M.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aanavi","family":"Karandikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie B.","family":"Hastings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8087-9120","authenticated-orcid":false,"given":"Rebecca A.","family":"Previs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0350-0110","authenticated-orcid":false,"given":"Venkataprasanth P.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor J.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakti H.","family":"Ramkissoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2023.03.008_bib1","doi-asserted-by":"crossref","first-page":"100399","DOI":"10.1016\/j.esmoop.2022.100399","article-title":"Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer","volume":"7","author":"Heitzer","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13073-019-0703-1","article-title":"Molecular profiling for precision cancer therapies","volume":"12","author":"Malone","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221112696","article-title":"The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer","volume":"14","author":"Ezeife","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jnci\/djy156","article-title":"A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers","volume":"111","author":"Sabari","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1","key":"10.1016\/j.jmoldx.2023.03.008_bib5","doi-asserted-by":"crossref","first-page":"S326","DOI":"10.1016\/j.jval.2020.04.1219","article-title":"PPM2 comprehensive genomic testing in advanced non-small cell lung cancer (NSCLC): a cost-effectiveness analysis of plasma-based circulating tumor DNA (CTDNA) next-generation sequencing (NGS) to inform first-line treatment decisions","volume":"23","author":"Lopes","year":"2020","journal-title":"Value Health"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/cancers14030777","article-title":"The use of ctDNA for BRAF mutation testing in routine clinical practice in patients with advanced melanoma","volume":"14","author":"Sobczuk","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2018.4305","article-title":"Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer","volume":"5","author":"Aggarwal","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib8","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jtho.2021.06.017","article-title":"Liquid biopsy for advanced NSCLC: a consensus statement from the International Association for the Study of Lung Cancer","volume":"16","author":"Rolfo","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.37349\/etat.2020.00020","article-title":"Diagnostic and prognostic role of liquid biopsy in non-small cell lung cancer: evaluation of circulating biomarkers","volume":"1","author":"Vicidomini","year":"2020","journal-title":"Explor Target Antitumor Ther"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib10","doi-asserted-by":"crossref","first-page":"644737","DOI":"10.3389\/fonc.2021.644737","article-title":"PIK3CA mutations as a molecular target for hormone receptor-positive, HER2-negative metastatic breast cancer","volume":"11","author":"Fusco","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib11","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.3390\/ijms23116320","article-title":"Targeting PIK3CA actionable mutations in the circulome: a proof of concept in metastatic breast cancer","volume":"23","author":"Cardinali","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3322\/caac.21650","article-title":"Circulating tumor DNA in advanced solid tumors: clinical relevance and future directions","volume":"71","author":"Cheng","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib13","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib14","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1200\/JCO.2008.16.2578","article-title":"Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer","volume":"26","author":"Di Leo","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib15","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.mayocpiqo.2021.05.003","article-title":"BRAF V600 mutation detection in plasma cell-free DNA: NCCTG N0879 (Alliance)","volume":"5","author":"Slostad","year":"2021","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.32471\/exp-oncology.2312-8852.vol-43-no-3.16592","article-title":"Plasma ctDNA RAS status selects patients for anti-EGFR treatment rechallenge in metastatic colorectal cancer: a meta-analysis","volume":"43","author":"Vlachou","year":"2021","journal-title":"Exp Oncol"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib17","doi-asserted-by":"crossref","first-page":"660924","DOI":"10.3389\/fcell.2021.660924","article-title":"Updates on clinical use of liquid biopsy in colorectal cancer screening, diagnosis, follow-up, and treatment guidance","volume":"9","author":"Mazouji","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/jamaoncol.2018.5080","article-title":"Rechallenge for patients with RAS and BRAF wild-type metastatic colorectal cancer with acquired resistance to first-line cetuximab and irinotecan: a phase 2 single-arm clinical trial","volume":"5","author":"Cremolini","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib19","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/gutjnl-2017-314178","article-title":"Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study","volume":"67","author":"Khan","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccell.2018.06.004","article-title":"Radiologic and genomic evolution of individual metastases during HER2 blockade in colorectal cancer","volume":"34","author":"Siravegna","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib21","doi-asserted-by":"crossref","first-page":"35289","DOI":"10.18632\/oncotarget.13311","article-title":"Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab","volume":"8","author":"Toledo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib22","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/2159-8290.CD-19-0442","article-title":"Tumor genomic profiling guides patients with metastatic gastric cancer to targeted treatment: the VIKTORY Umbrella Trial","volume":"9","author":"Lee","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib23","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41591-019-0561-9","article-title":"Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers","volume":"25","author":"Parikh","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1158\/2159-8290.CD-17-0395","article-title":"Genomic heterogeneity as a barrier to precision medicine in gastroesophageal adenocarcinoma","volume":"8","author":"Pectasides","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib25","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1158\/1078-0432.CCR-17-3103","article-title":"Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced cancers of the gastrointestinal tract or anus","volume":"24","author":"Schrock","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2017.10.032","article-title":"HER2 copy number of circulating tumour DNA functions as a biomarker to predict and monitor trastuzumab efficacy in advanced gastric cancer","volume":"88","author":"Wang","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12916-021-02109-y","article-title":"Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study","volume":"19","author":"Qiao","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/cancers11050736","article-title":"Detecting and tracking circulating tumour DNA copy number profiles during first line chemotherapy in oesophagogastric adenocarcinoma","volume":"11","author":"Davidson","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12876-020-01531-5","article-title":"HER2 gene assessment in liquid biopsy of gastric and esophagogastric junction cancer patients qualified for surgery","volume":"20","author":"Grenda","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib30","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1158\/1078-0432.CCR-18-1128","article-title":"Analysis of circulating tumor DNA and clinical correlates in patients with esophageal, gastroesophageal junction, and gastric adenocarcinoma","volume":"24","author":"Kato","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib31","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1158\/1078-0432.CCR-19-1704","article-title":"Circulating tumor DNA sequencing analysis of gastroesophageal adenocarcinoma","volume":"25","author":"Maron","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib32","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3390\/curroncol29030120","article-title":"Circulating tumor DNA in gastric and gastroesophageal junction cancer","volume":"29","author":"Paschold","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib33","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1038\/s41467-022-30380-x","article-title":"Automated next-generation profiling of genomic alterations in human cancers","volume":"13","author":"Keefer","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib35","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib36","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa7161","article-title":"Personalized genomic analyses for cancer mutation discovery and interpretation","volume":"7","author":"Jones","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar7939","article-title":"A machine learning approach for somatic mutation discovery","volume":"10","author":"Wood","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib40","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1093\/nar\/gkw227","article-title":"VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research","volume":"44","author":"Lai","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib41","doi-asserted-by":"crossref","first-page":"16156","DOI":"10.1073\/pnas.202610899","article-title":"Digital karyotyping","volume":"99","author":"Wang","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib42","doi-asserted-by":"crossref","first-page":"162ra154","DOI":"10.1126\/scitranslmed.3004742","article-title":"Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing","volume":"4","author":"Leary","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib43","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1158\/1078-0432.CCR-19-1372","article-title":"Noninvasive detection of microsatellite instability and high tumor mutation burden in cancer patients treated with PD-1 blockade","volume":"25","author":"Georgiadis","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib44","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/jnci\/djy105","article-title":"Circulating tumor DNA assays in clinical cancer research","volume":"110","author":"Ossandon","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib45","doi-asserted-by":"crossref","first-page":"e1774","DOI":"10.1200\/OP.20.01023","article-title":"Association between Medicare's national coverage determination and utilization of next-generation sequencing","volume":"17","author":"Sheinson","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib46","doi-asserted-by":"crossref","first-page":"866","DOI":"10.6004\/jnccn.2020.7542","article-title":"Private payer and Medicare coverage for circulating tumor DNA testing: a historical analysis of coverage policies from 2015 to 2019","volume":"18","author":"Douglas","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib47","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/cncr.33571","article-title":"High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: the Korean Lung Liquid Versus Invasive Biopsy Program","volume":"127","author":"Park","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib48","first-page":"156","article-title":"Concordance analysis between liquid biopsy (ctDNA) and tumor DNA molecular profiles from panel-based next-generation sequencing","volume":"55","author":"Rodon Font","year":"2022","journal-title":"Rev Esp Patol"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib49","doi-asserted-by":"crossref","first-page":"e1971","DOI":"10.1002\/onco.13905","article-title":"Validation of a circulating tumor DNA-based next-generation sequencing assay in a cohort of patients with solid tumors: a proposed solution for decentralized plasma testing","volume":"26","author":"Al Zoughbi","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.jmoldx.2023.03.008_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"}],"updated-by":[{"DOI":"10.1016\/j.jmoldx.2023.08.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000}}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157823000752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157823000752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:04:08Z","timestamp":1697259848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157823000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1525157823000752"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2023.03.008","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jmoldx.2023.08.001","asserted-by":"object"}]},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the Labcorp Plasma Focus Test to Facilitate Precision Oncology Through Cell-Free DNA Genomic Profiling of Solid Tumors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2023.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}